Keene & Associates, Inc. Organon & Co. Transaction History

Keene & Associates, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$10.95 - $17.32 $549,295 - $868,840	-50,164 Reduced 40.2%	74,623 $1.08 Million
Q3 2023 Oct 13, 2023	BUY	$16.59 - $23.77 $153,590 - $220,062	9,258 Added 8.01%	124,787 $2.17 Million
Q2 2023 Jul 26, 2023	BUY	$19.27 - $24.63 $58,388 - $74,628	3,030 Added 2.69%	115,529 $2.4 Million
Q1 2023 Apr 19, 2023	BUY	$21.42 - $32.08 $1.15 Million - $1.72 Million	53,467 Added 90.57%	112,499 $2.65 Million
Q4 2022 Feb 09, 2023	SELL	$23.31 - $28.61 $868,926 - $1.07 Million	-37,277 Reduced 38.71%	59,032 $1.65 Million
Q3 2022 Nov 01, 2022	BUY	$23.4 - $34.25 $58,757 - $86,001	2,511 Added 2.68%	96,309 $2.25 Million
Q2 2022 Jul 21, 2022	BUY	$31.66 - $38.9 $232,352 - $285,487	7,339 Added 8.49%	93,798 $3.17 Million
Q1 2022 Apr 12, 2022	SELL	$30.45 - $39.36 $72,471 - $93,676	-2,380 Reduced 2.68%	86,459 $3.02 Million
Q4 2021 Jan 31, 2022	BUY	$28.67 - $37.13 $2.55 Million - $3.3 Million	88,839 New	88,839 $2.71 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Keene & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Keene & Associates, Inc. with notifications on news.